(Q44168559)

English

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans

scientific article published on 25 January 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

avian influenza

1 reference

based on heuristic

inferred from title

author name string

Wendy Peters

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jennifer R Brandl

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jonathan D Lindbloom

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

C Josefina Martinez

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ciaran D Scallan

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

George R Trager

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Debora W Tingley

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Martin L Kabongo

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sean N Tucker

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

25 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1752-1758

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Detecting human-to-human transmission of avian influenza A (H5N1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Pandemic (avian) influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Airborne transmission of influenza A/H5N1 virus between ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Oral adenoviral-based vaccines: historical perspective and future opportunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Phenotypic Changes in Influenza‐Specific CD8+T Cells after Immunization of Children and Adults with Influenza Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.023

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.01.023

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44168559&oldid=2108229407"